subject: CHEBI:3699

subject_name: Cimetidine

object_name: X-linked erythropoietic protoporphyria


subject: CHEBI:3699

object_name: erythropoietic protoporphyria

tested_intervention: yes


subject: CHEBI:3699

object_name: protoporphyria, erythropoietic, 1


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Advanced Head and Neck Squamous Cell Carcinoma

tested_intervention: unsure


subject: CHEBI:4672

object_name: Head and neck cancer metastatic


subject: CHEBI:4672

object_name: Advanced Head and Neck Carcinoma


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: Squamous cell carcinoma of head and neck recurrent


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: CHEBI:64816

object_name: type C thymoma


subject: CHEBI:64816

object_name: thymoma


subject: CHEBI:64816

object_name: thymus neoplasm


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UMLS:C3642261

subject_name: Copper Cu 62 Ethylglyoxal Bis(thiosemicarbazone)

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C3642261

object_name: clear cell renal carcinoma


subject: UMLS:C3642261

object_name: renal cell adenocarcinoma


subject: UMLS:C3642261

object_name: renal cell carcinoma


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: diabetic macular edema


subject: CHEBI:136051

subject_name: Lusutrombopag

object_name: autoimmune thrombocytopenia


subject: CHEBI:136051

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Metastatic Colorectal Adenocarcinoma


subject: CHEBI:36704

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:36704

object_name: Stage IV Colorectal Cancer AJCC v7


subject: CHEBI:36704

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: CHEBI:36704

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: CHEBI:36704

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:JEA93WJ5DG

subject_name: SOTIGALIMAB


subject: UNII:JEA93WJ5DG


subject: UNII:JEA93WJ5DG


subject: UNII:JEA93WJ5DG


subject: UNII:JEA93WJ5DG


subject: UNII:JEA93WJ5DG


subject: UMLS:C4053581


subject: UMLS:C4053581


subject: UMLS:C4053581


subject: UMLS:C4053581


subject: UMLS:C4053581


subject: UMLS:C4053581


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: chronic disease


subject: CHEBI:50731

object_name: Chronic Disease


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:7465

subject_name: Naltrexone


subject: CHEBI:7465


subject: UMLS:C2719312

subject_name: Embeda


subject: UMLS:C2719312


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Mesothelioma malignant recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Mesothelioma malignant localised


subject: UNII:2S9ZZM9Q9V

object_name: malignant epithelioid mesothelioma


subject: UNII:2S9ZZM9Q9V

object_name: sarcomatoid mesothelioma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:231594

subject_name: Norgestrel


subject: CHEBI:10033

subject_name: Warfarin


subject: UMLS:C3273311

subject_name: Gynoflor

object_name: paroxysmal familial ventricular fibrillation


subject: UMLS:C3273311

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: CHEBI:9123

subject_name: Sertraline

object_name: Chronic recurrent major depressive disorder


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: Pruritus


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:7774

subject_name: Zofran


subject: CHEBI:138016

subject_name: MPA

object_name: Menorrhagia


subject: CHEBI:138016

object_name: Menorrhagia, CTCAE


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: PR:000012478

subject_name: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha


subject: PR:000012478


subject: UniProtKB:P27664

subject_name: PDE6A_MOUSE Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (sprot)


subject: UniProtKB:P27664


subject: UMLS:C4723628

subject_name: A-101 Topical Solution

object_name: seborrheic keratosis


subject: PUBCHEM.COMPOUND:118110201

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:118110201

object_name: Secondary malignant neoplasm of lung


subject: PUBCHEM.COMPOUND:118110201

object_name: Stage IV Lung Cancer AJCC v7


subject: UNII:DSP7A26K25


subject: UNII:DSP7A26K25


subject: UNII:DSP7A26K25


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:83766

subject_name: Olaparib

object_name: Cholangiocarcinoma recurrent


subject: CHEBI:83766

object_name: Recurrent Glioma


subject: CHEBI:83766

object_name: grade II glioma


subject: CHEBI:83766

object_name: grade III glioma


subject: UNII:926F8X7TNO

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:926F8X7TNO

object_name: non-Hodgkin lymphoma


subject: UNII:926F8X7TNO

object_name: neoplasm


subject: GTOPDB:2479

subject_name: HCl

object_name: Blood Pressure Finding


subject: GTOPDB:2479

object_name: Systemic arterial pressure


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C1512523


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: UMLS:C0443985


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: CHEBI:17883


subject: UMLS:C2703095

object_name: cervical cancer


subject: UMLS:C2703095

object_name: cervical carcinoma


subject: CHEBI:75998

subject_name: Trametinib


subject: UNII:ZXM835LQ5E

subject_name: Uprosertib


subject: UNII:ZXM835LQ5E


subject: UMLS:C2830127


subject: UMLS:C2830127


subject: MESH:C533727

object_name: Chronic constipation


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage II Cervical Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Cervical Cancer AJCC v6


subject: CHEBI:74705

subject_name: Met-Leu

object_name: bronchiectasis


subject: CHEBI:74705

object_name: cystic disease of lung


subject: CHEBI:74705

object_name: Pulmonary cyst


subject: CHEBI:74705

object_name: bronchopulmonary dysplasia


subject: CHEBI:74705

object_name: Chronic atelectasis


subject: CHEBI:74705

object_name: tracheomalacia


subject: CHEBI:74705

object_name: Vascular ring


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: UMLS:C0034862

subject_name: Vaccines, Recombinant

object_name: Condylomata acuminata in women


subject: UMLS:C0034862

object_name: Condylomata acuminata in men


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Recurrent Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:3219

subject_name: Bupropion

object_name: Suicidal behavior


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: alcohol abuse


subject: CHEBI:5118

object_name: alcohol dependence


subject: CHEBI:5118


subject: UNII:L63605PZ70

subject_name: TALAPORFIN SODIUM

object_name: Neoplasm Recurrence, Local


subject: UMLS:C1312955

subject_name: talaporfin sodium


subject: CHEBI:135875

subject_name: Talaporfin


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: chronic rhinosinusitis


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:28918

subject_name: Epinephrine


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: cholangiocarcinoma


subject: CHEBI:36467

subject_name: Ciguatoxins

object_name: Myelodysplasia


subject: CHEBI:36467

object_name: Refractory acute myeloid leukemia


subject: CHEBI:36467

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:36467

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:204928

subject_name: Cefotaxime


subject: CHEBI:204928


subject: CHEBI:204928


subject: CHEBI:204928


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C5574748


subject: UMLS:C5574748


subject: UMLS:C5574748


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UMLS:C0010377


subject: UMLS:C0010377


subject: UMLS:C0010377


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: UniProtKB:P41416


subject: UniProtKB:P41416


subject: UniProtKB:P41416


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: UMLS:C0700805

subject_name: Fludara


subject: UMLS:C0700805


subject: UMLS:C0700805


subject: CHEBI:135117

subject_name: ftivazide

object_name: Pregnant


subject: CHEBI:135117

object_name: Human Immunodeficiency Virus Positive


subject: CHEBI:6030

subject_name: Isoniazid


subject: CHEBI:6030


subject: HMDB:HMDB0015332

subject_name: Rifapentine


subject: HMDB:HMDB0015332


subject: CHEBI:80755

object_name: acute lymphoblastic leukemia


subject: CHEBI:80755

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:131182


subject: PUBCHEM.COMPOUND:131182


subject: PUBCHEM.COMPOUND:57889181

object_name: rheumatoid arthritis


subject: UMLS:C3886791


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:3215

object_name: Closed fracture of hip


subject: CHEBI:9130

subject_name: Sevoflurane


subject: UMLS:C3541386

subject_name: Estrogens, endocrine therapy drugs

object_name: Hyperplasia of the endometrium


subject: UMLS:C3541386

object_name: uterine disease


subject: UMLS:C3537250

subject_name: ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM


subject: UMLS:C3537250


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: UMLS:C3714615

subject_name: Estrogens Drug Class


subject: UMLS:C3714615


subject: UMLS:C0301869

subject_name: Immunostimulating conjugate (antigen)

object_name: Menopause present (finding)


subject: UMLS:C0301869

object_name: Menopause


subject: UMLS:C0301869


subject: UMLS:C0301869


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: migraine


subject: CHEBI:37941

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:201431

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:201431

object_name: Recurrent Mixed Phenotype Acute Leukemia


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3368

object_name: mixed phenotype acute leukemia


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: Refractory Mixed Phenotype Acute Leukemia


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:33704

subject_name: Amino acid


subject: CHEBI:33704


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: UMLS:C3843379

subject_name: Patch estrogen


subject: UMLS:C3843379


subject: UMLS:C0892938

subject_name: OGT 918

object_name: Niemann-Pick disease


subject: CHEBI:6931

subject_name: Midazolam

object_name: Postoperative Nausea


subject: CHEBI:6931

object_name: Vomiting, Postoperative


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C3827082


subject: UNII:R1UQ6D1ECM

subject_name: ENTOLIMOD

object_name: Substance Use Disorders


subject: UMLS:C2353146


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: respiratory tract infectious disorder


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:U59UGK3IPC

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:U59UGK3IPC

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UNII:38073MQB2A

subject_name: Umbralisib


subject: UNII:38073MQB2A

object_name: non-Hodgkin lymphoma


subject: UNII:38073MQB2A


subject: UNII:38073MQB2A


subject: CHEBI:75929

object_name: phobic disorder


subject: CHEBI:40009

subject_name: Cycloserine


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: aortic valve disease 2


subject: PUBCHEM.COMPOUND:73151030

object_name: aortic stenosis


subject: PUBCHEM.COMPOUND:73151030

object_name: aortic valve disease 3


subject: PUBCHEM.COMPOUND:73151030

object_name: Stenosis of aorta


subject: UNII:M3H4D91AY5

subject_name: Rencofilstat

object_name: liver disorder


subject: UNII:M3H4D91AY5

object_name: infectious disease


subject: UNII:M3H4D91AY5

object_name: hepatitis B


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63625


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: UniProtKB:P36394


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PR:000015643


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Malignant neoplasm of abdomen


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: breast neoplasm


subject: CHEBI:174615

object_name: combined immunodeficiency due to DOCK8 deficiency


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:36467

subject_name: Ciguatoxins


subject: CHEBI:204928

subject_name: Cefotaxime


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: UMLS:C0699319

subject_name: Cytoxan


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: UMLS:C0700805


subject: CHEBI:5384

subject_name: Glipizide

object_name: genotype


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Membranous Nephropathy - PLA2R Induced


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:4026


subject: CHEBI:4027


subject: CHEBI:51041

subject_name: Acamprosate

object_name: fragile X syndrome


subject: PUBCHEM.COMPOUND:73417116

subject_name: TRANYLCYPROMINE

object_name: acute myeloid leukemia


subject: CHEBI:182949

subject_name: Tranylcypromine


subject: CHEBI:50949

subject_name: serotonin uptake inhibitor

object_name: Urinary Urgency


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: superficial urinary bladder carcinoma


subject: UMLS:C2346454


subject: UMLS:C4551744

subject_name: Tazocin

object_name: Sepsis


subject: UMLS:C4551744

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Metastatic malignant neoplasm to peritoneum


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:408174

subject_name: Arformoterol


subject: UNII:A14FB57V1D

subject_name: GLYCOPYRRONIUM


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Shoulder pain


subject: CHEBI:60789

object_name: musculoskeletal system disorder


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: sexually transmitted disease


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: CHEBI:173106

subject_name: ferroptocide


subject: CHEBI:44915

subject_name: Propofol

object_name: Chronic Insomnia


subject: CHEBI:44915

object_name: Sleep Deprivation


subject: CHEBI:44915

object_name: insomnia


subject: CHEBI:44915

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:44915

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:44915

object_name: Sleep Quality


subject: CHEBI:44915

object_name: REM sleep behavior disorder


subject: CHEBI:44915

object_name: Insomnia due to other mental disorder


subject: CHEBI:44915

object_name: Insomnia Related to Specified Disorder


subject: CHEBI:44915

object_name: Shift-Work Sleep Disorder


subject: CHEBI:44915

object_name: Military activity


subject: CHEBI:44915

object_name: circadian rhythm sleep disorder


subject: CHEBI:44915

object_name: Menopause related conditions


subject: CHEBI:44915

object_name: Insomnia due to anxiety and fear


subject: CHEBI:44915

object_name: Complex posttraumatic stress disorder


subject: CHEBI:44915

object_name: post-traumatic stress disorder


subject: CHEBI:44915

object_name: cancer pain


subject: CHEBI:44915

object_name: military combat stress reaction


subject: CHEBI:44915

object_name: recurrent hypersomnia


subject: CHEBI:44915

object_name: idiopathic hypersomnia


subject: CHEBI:44915

object_name: anxiety


subject: CHEBI:44915

object_name: anxiety disorder


subject: CHEBI:44915

object_name: Anxiety symptoms


subject: CHEBI:44915

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:44915

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:44915

object_name: BH4-deficient hyperphenylalaninemia A


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: endometrial cancer


subject: UMLS:C0919079

object_name: uterine corpus cancer


subject: UMLS:C0919079

object_name: endometrial carcinoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C5238362

subject_name: EGFR/HER2 Inhibitor DZD9008

object_name: non-small cell lung carcinoma


subject: UMLS:C1735945

subject_name: Symbicort Turbuhaler

object_name: asthma


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: UMLS:C5420424

subject_name: Encapsulated Rapamycin

object_name: Adenomatous colonic polyposis


subject: CHEBI:7824

subject_name: Oxcarbazepine


subject: CHEBI:151315

subject_name: Heparin

object_name: fetal growth restriction


subject: CHEBI:151315

object_name: Fetal Death


subject: CHEBI:151315

object_name: placental abruption


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN

object_name: preeclampsia


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: HER2-positive gastric cancer


subject: GTOPDB:13716

object_name: Malignant neoplasm of stomach stage IV


subject: GTOPDB:13716

object_name: Unresectable Gastric Carcinoma


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UNII:RB3U3A1S27


subject: UNII:RB3U3A1S27


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: MESH:C079198

subject_name: S 1 (combination)


subject: MESH:C079198


subject: MESH:C079198


subject: UMLS:C4508324

object_name: neurodegenerative disease


subject: UMLS:C4508324

object_name: Alzheimer disease type 1


subject: UMLS:C4508324

object_name: Alzheimer disease


subject: UMLS:C4508324

object_name: Parkinson disease


subject: UMLS:C4508324

object_name: mild neurocognitive disorder


subject: UMLS:C4508324

object_name: mild cognitive impairment


subject: CHEBI:31932

subject_name: olmesartan

object_name: coronary artery disorder


subject: CHEBI:31932

object_name: coronary atherosclerosis


subject: DRUGBANK:DB18786

object_name: diabetic macular edema


subject: DRUGBANK:DB18786

object_name: diabetic retinopathy


subject: DRUGBANK:DB18786

object_name: proliferative diabetic retinopathy


subject: DRUGBANK:DB18786

object_name: background diabetic retinopathy


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Advanced Colorectal Carcinoma


subject: UNII:PQX0D8J21J

object_name: Advanced Colorectal Adenocarcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C2703210

object_name: colorectal cancer


subject: UMLS:C2703210

object_name: colorectal carcinoma


subject: UMLS:C2703210

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2703210


subject: UMLS:C2703210

object_name: metastatic colorectal cancer


subject: UMLS:C2703210


subject: UMLS:C2703210

object_name: colorectal adenocarcinoma


subject: CHEBI:78825

subject_name: Avutometinib


subject: CHEBI:78825


subject: CHEBI:78825


subject: CHEBI:78825


subject: CHEBI:78825


subject: CHEBI:78825


subject: CHEBI:78825


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: cystinuria


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: UMLS:C0726406

subject_name: Glycolic Acid 70%

object_name: Solar elastosis


subject: CHEBI:64816

object_name: gastric adenocarcinoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:J6K8WSV73A

subject_name: Quemliclustat

object_name: carcinoma of biliary tract


subject: UNII:J6K8WSV73A

object_name: bile duct carcinoma


subject: UNII:J6K8WSV73A

object_name: bile duct cancer


subject: UNII:J6K8WSV73A

object_name: cholangiocarcinoma


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: GTOPDB:13716

object_name: urothelial carcinoma


subject: GTOPDB:13716

object_name: transitional cell carcinoma


subject: UNII:RB3U3A1S27


subject: UNII:RB3U3A1S27


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: esophagogastric junction disorder


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: MESH:C586502

subject_name: tegafur-gimeracil-oteracil

object_name: esophageal adenocarcinoma


subject: MESH:C586502

object_name: lung adenocarcinoma


subject: MESH:C586502

object_name: cervical adenocarcinoma


subject: MESH:C586502

object_name: adenocarcinoma


subject: MESH:C586502

object_name: bile duct adenocarcinoma


subject: MESH:C586502


subject: MESH:C586502


subject: MESH:C586502

object_name: gastric neoplasm


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: brain disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEMBL.COMPOUND:CHEMBL1200571

subject_name: GADOBENATE DIMEGLUMINE

object_name: Blood brain barrier defect


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Central nervous system lesion


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UMLS:C4287722

subject_name: GBCA P03277


subject: UMLS:C4287722


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Primary osteoarthritis of knee NOS


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:6909

subject_name: Metronidazole

object_name: rosacea


subject: CHEBI:50838

subject_name: Drospirenone

object_name: Blood Pressure Finding


subject: CHEBI:50838

object_name: Systemic arterial pressure


subject: PR:000012938

subject_name: pinin


subject: PR:000012938


subject: CHEBI:9112

subject_name: sennoside A

object_name: Gastroparesis due to diabetes mellitus


subject: DRUGBANK:DB15889

subject_name: Senna leaf


subject: CHEMBL.COMPOUND:CHEMBL2108558

subject_name: SENNA


subject: UNII:3FYP5M0IJX

subject_name: Sennosides


subject: CHEBI:534

subject_name: Docusate


subject: MESH:D010919

subject_name: Placebos

object_name: Hot Flashes, CTCAE


subject: MESH:D010919

object_name: Hot flashes


subject: CHEBI:28694

subject_name: Copper

object_name: Parkinson disease


subject: CHEBI:29036

subject_name: Cupric cation


subject: CHEBI:74067

subject_name: Ile-Ile


subject: PR:000001822

subject_name: MHC class II histocompatibility antigen gamma chain


subject: PR:000007904


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: CHEBI:35341

subject_name: steroid

object_name: Meniere disease


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: CHEBI:77590

subject_name: Armodafinil

object_name: brain neoplasm


subject: CHEBI:77590

object_name: nervous system neoplasm


subject: CHEBI:77590

object_name: cognitive disorder


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: CHEBI:31859


subject: CHEBI:48520

subject_name: Xaliproden

object_name: colorectal carcinoma


subject: CHEBI:48520

object_name: Embolism, Tumor


subject: CHEBI:48520

object_name: Neoplasm Metastasis


subject: CHEBI:48520

object_name: Metastatic Lesion


subject: CHEBI:48520

object_name: colorectal neoplasm


subject: UNII:7P55415B0R

object_name: Alzheimer Disease, Early Onset


subject: UNII:7P55415B0R

object_name: Amnestic mild cognitive disorder


subject: UNII:7P55415B0R

object_name: amnesia


subject: UNII:7P55415B0R

object_name: Amnestic symptoms


subject: CHEBI:3509

object_name: Infection


subject: CHEBI:3509

object_name: infectious disease


subject: CHEBI:3509

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:6321415

subject_name: ceftazidime


subject: PUBCHEM.COMPOUND:6321415


subject: PUBCHEM.COMPOUND:6321415


subject: GTOPDB:13536

subject_name: tofersen

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: GTOPDB:13536

object_name: amyotrophic lateral sclerosis


subject: UNII:2NU6F9601K

subject_name: Tofersen


subject: UNII:2NU6F9601K


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: acquired partial lipodystrophy


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: physiologic resolution


subject: PUBCHEM.COMPOUND:9831414

object_name: Friction blister


subject: PUBCHEM.COMPOUND:9831414

object_name: Bulla


subject: PUBCHEM.COMPOUND:9831414

object_name: Blister of skin AND/OR mucosa


subject: PUBCHEM.COMPOUND:9831414

object_name: Skin bulla


subject: PUBCHEM.COMPOUND:9831414

object_name: Blistering eruption


subject: PUBCHEM.COMPOUND:9831414

object_name: Dermatitis


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: DRUGBANK:DB11357

subject_name: Linseed oil

object_name: Chronic Kidney Disease, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: chronic kidney disease


subject: CHEMBL.COMPOUND:CHEMBL2107910


subject: UNII:J7M4Z2D183

subject_name: Aroplatin

object_name: pancreatic neoplasm


subject: DRUGBANK:DB17319


subject: UMLS:C0125061

subject_name: L-NDDP


subject: CHEBI:23359

subject_name: colchicine

object_name: type 1 diabetes mellitus


subject: CHEBI:23359

object_name: Chronic inflammation


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:16526

subject_name: Carbon dioxide

object_name: Nasal Congestion, CTCAE


subject: CHEBI:16526

object_name: Nasal congestion


subject: CHEBI:134689

subject_name: Rucaparib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Disorder of hip region


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UMLS:C5237235

subject_name: Neoantigen-based Therapeutic Cancer Vaccine GRT-C903

object_name: Childhood Solid Neoplasm


subject: UMLS:C5237235

object_name: Adult Solid Neoplasm


subject: UMLS:C5237235

object_name: Solid Neoplasm


subject: UMLS:C5237235


subject: UMLS:C5237235

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5237235

object_name: malignant pancreatic neoplasm


subject: UMLS:C5237235

object_name: non-small cell lung carcinoma


subject: UMLS:C5237235

object_name: colorectal cancer


subject: UMLS:C5237235

object_name: colorectal carcinoma


subject: UMLS:C5237235

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5237236

subject_name: Neoantigen-based Therapeutic Cancer Vaccine GRT-R904


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: UMLS:C5237236

object_name: pancreatic neoplasm


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Adult Gliosarcoma


subject: UNII:52CMI0WC3Y

object_name: gliosarcoma


subject: UNII:52CMI0WC3Y

object_name: Childhood Gliosarcoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:74705

subject_name: Met-Leu

object_name: ST-elevation myocardial infarction


subject: CHEBI:74705

object_name: Acute non-ST segment elevation myocardial infarction (disorder)


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:5100

subject_name: Flucytosine

object_name: CRYPTOCOCCAL INFECTION DISSEMINATED


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED


subject: CHEBI:46081

subject_name: Fluconazole


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: kidney failure


subject: PUBCHEM.COMPOUND:11431811

subject_name: Tiotropium Bromide Monohydrate


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: homocystinuria


subject: CHEBI:23965

subject_name: estradiol

object_name: schizophreniform disorder


subject: UMLS:C5888788

subject_name: Cytarabine Liquid Injection

object_name: primary central nervous system lymphoma


subject: UNII:PF8K38CG54

subject_name: Fremanezumab

object_name: migraine with aura


subject: UNII:PF8K38CG54

object_name: Common Migraine


subject: UNII:PF8K38CG54

object_name: brain disorder


subject: UMLS:C2047258

subject_name: human papilloma virus vaccine, quadrivalent

object_name: human papilloma virus infection


subject: UMLS:C2047258

object_name: female reproductive system disorder


subject: UMLS:C0540301

subject_name: C1 esterase inhibitor

object_name: multiple organ dysfunction syndrome


subject: UMLS:C0540301

object_name: Physical trauma


subject: UMLS:C0540301

object_name: Injury


subject: UMLS:C0540301

object_name: Trauma


subject: UMLS:C0540301

object_name: Sepsis


subject: UMLS:C0540301

object_name: Sepsis, CTCAE


subject: UMLS:C0009500

subject_name: Complement C1 Inactivator Proteins


subject: UMLS:C0009500


subject: UMLS:C0009500


subject: UMLS:C0009500


subject: UMLS:C0009500


subject: UMLS:C0009500


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: prolymphocytic leukemia


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:11654566

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: pulmonary hypertension, primary, 1


subject: UMLS:C0013227

object_name: pulmonary hypertension


subject: UMLS:C0013227

object_name: idiopathic pulmonary arterial hypertension


subject: UMLS:C0013227

object_name: pulmonary arterial hypertension


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:145831

subject_name: monoacylglycerol 16:5

object_name: diabetic neuropathy


subject: CHEBI:145831

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: Metastatic Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:91826462

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:31348

subject_name: Capecitabine

object_name: adult lymphoma


subject: CHEBI:31348

object_name: lymphoma


subject: CHEBI:31348

object_name: pediatric lymphoma


subject: CHEBI:31348

object_name: metastatic prostate carcinoma


subject: CHEBI:31348

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:31348

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:31348

object_name: Solid carcinoma


subject: CHEBI:31348

object_name: solid carcinoma of stomach


subject: CHEBI:31348

object_name: cutaneous squamous cell carcinoma


subject: CHEBI:31348

object_name: basal cell carcinoma


subject: CHEBI:31348

object_name: skin basal cell carcinoma


subject: CHEBI:31348

object_name: malignant soft tissue neoplasm


subject: UMLS:C4764033

subject_name: Super Enhancer Inhibitor GZ17-6.02

object_name: Childhood Breast Carcinoma


subject: UMLS:C4764033

object_name: breast carcinoma


subject: UMLS:C4764033

object_name: breast cancer


subject: UMLS:C4764033

object_name: Childhood Solid Neoplasm


subject: UMLS:C4764033

object_name: Adult Solid Neoplasm


subject: UMLS:C4764033

object_name: Solid Neoplasm


subject: UMLS:C4764033

object_name: adult lymphoma


subject: UMLS:C4764033

object_name: lymphoma


subject: UMLS:C4764033

object_name: pediatric lymphoma


subject: UMLS:C4764033

object_name: Advanced cancer


subject: UMLS:C4764033

object_name: metastatic prostate carcinoma


subject: UMLS:C4764033

object_name: pancreatic neoplasm


subject: UMLS:C4764033

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4764033

object_name: malignant pancreatic neoplasm


subject: UMLS:C4764033

object_name: Stomach cancer


subject: UMLS:C4764033

object_name: gastric cancer


subject: UMLS:C4764033

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C4764033

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C4764033

object_name: colorectal carcinoma


subject: UMLS:C4764033

object_name: Solid carcinoma


subject: UMLS:C4764033

object_name: solid carcinoma of stomach


subject: UMLS:C4764033

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4764033

object_name: skin squamous cell carcinoma


subject: UMLS:C4764033

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C4764033

object_name: basal cell carcinoma


subject: UMLS:C4764033

object_name: skin basal cell carcinoma


subject: UMLS:C4764033

object_name: malignant soft tissue neoplasm


subject: UMLS:C4764033

object_name: sarcoma


subject: UMLS:C1095795

subject_name: EGb 761

object_name: Age-Related Memory Disorders


subject: UMLS:C1095795

object_name: Memory Disorders


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: acute myocardial infarction


subject: MESH:D000077203

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C3542461


subject: CHEBI:135117

subject_name: ftivazide

object_name: Poisoning by isoniazid


subject: CHEBI:135117

object_name: isoniazid toxicity


subject: CHEBI:6030

subject_name: Isoniazid


subject: CHEBI:6030


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: High grade glioma


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0058773

subject_name: Diphtheria-Tetanus Vaccine


subject: UMLS:C0058773

object_name: malignant glioma


subject: CHEBI:231601

subject_name: trastuzumab

object_name: esophageal squamous cell carcinoma


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: leukemia


subject: UMLS:C0770694

object_name: childhood leukemia


subject: UMLS:C0770694

object_name: Infection


subject: UMLS:C0770694

object_name: infectious disease


subject: UMLS:C0770694

object_name: Adverse Event Associated with Infection


subject: GTOPDB:10236

subject_name: volociximab

object_name: ovarian cancer


subject: GTOPDB:10236

object_name: ovarian neoplasm


subject: GTOPDB:10236

object_name: ovarian carcinoma


subject: GTOPDB:10236

object_name: peritoneal neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108061

subject_name: VOLOCIXIMAB


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: UMLS:C1541160


subject: UMLS:C1541160


subject: UMLS:C1541160


subject: UMLS:C1541160


subject: UNII:JGH8MYC891

subject_name: drotrecogin alfa activated

object_name: Sepsis


subject: UNII:JGH8MYC891

object_name: Sepsis, CTCAE


subject: GTOPDB:8267

subject_name: milatuzumab

object_name: adult lymphoma


subject: GTOPDB:8267

object_name: lymphoma


subject: GTOPDB:8267

object_name: pediatric lymphoma


subject: UNII:2OP4E0GC6V


subject: UNII:2OP4E0GC6V


subject: UNII:2OP4E0GC6V


subject: UMLS:C2716103


subject: UMLS:C2716103


subject: UMLS:C2716103


subject: GTOPDB:8268

subject_name: veltuzumab


subject: GTOPDB:8268


subject: GTOPDB:8268


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UNII:BPD4DGQ314


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: UMLS:C1529789


subject: DRUGBANK:DB05385

object_name: chlamydia infectious disease


subject: DRUGBANK:DB05385

object_name: genital herpes


subject: DRUGBANK:DB05385

object_name: gonorrhea


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: herpes zoster


subject: PUBCHEM.COMPOUND:21634109

object_name: postherpetic neuralgia


subject: UMLS:C2003462

object_name: pancreatic neoplasm


subject: UMLS:C2003462

object_name: colorectal neoplasm


subject: UMLS:C2003462

object_name: melanoma


subject: CHEBI:149504

object_name: Arthrofibrosis


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:7769

subject_name: Olopatadine

object_name: vasomotor rhinitis


subject: UMLS:C2608294

subject_name: Nasal Spray brand of phenylephrine


subject: UNII:1B56C968OA

subject_name: Becaplermin

object_name: Diabetic foot ulcer


subject: CHEBI:90881

subject_name: Camptosar

object_name: digestive system neoplasm


subject: CHEBI:90881

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:90881

object_name: intestinal cancer


subject: CHEBI:90881

object_name: intestinal neoplasm


subject: CHEBI:8988


subject: CHEBI:8988


subject: UMLS:C4760648


subject: UMLS:C4760648

object_name: Neoplasm Metastasis


subject: UMLS:C4760648


subject: UMLS:C4760648


subject: UMLS:C4760648


subject: UMLS:C4760648


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: enteropathy-associated T-cell lymphoma


subject: UNII:8M7YSN2KII

object_name: ALK-negative anaplastic large cell lymphoma


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UMLS:C1579319

subject_name: pneumococcal conjugate vaccine

object_name: Primary mediastinal large B-cell lymphoma (PMBCL)


subject: UMLS:C1579319

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1579319

object_name: follicular lymphoma


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:91820602

object_name: Plasma cell myeloma recurrent


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C1699394


subject: PUBCHEM.COMPOUND:122443488

subject_name: SELVIGALTIN


subject: PUBCHEM.COMPOUND:122443488


subject: UMLS:C5783659

subject_name: Selvigaltin


subject: UMLS:C5783659


subject: UNII:72W09924WP

subject_name: Asoprisnil

object_name: Metrorrhagia


subject: UNII:72W09924WP

object_name: heavy bleeding between periods (symptom)


subject: UNII:4I67US2V8Q

object_name: Parkinson disease


subject: UNII:4I67US2V8Q

object_name: Motor Disorders


subject: UNII:XSZ53G39H5

subject_name: Brolucizumab

object_name: age-related macular degeneration


subject: CHEBI:478164

subject_name: Cefepime

object_name: septic shock


subject: UMLS:C0250480

subject_name: piperacillin-tazobactam combination


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: type 2 diabetes mellitus


subject: CHEBI:8378

subject_name: Prednisolone

object_name: tuberculosis


subject: CHEBI:8378

object_name: HIV infection


subject: CHEBI:233309

subject_name: Adagrasib

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:72317

subject_name: Cabozantinib


subject: PUBCHEM.COMPOUND:169292289

subject_name: darlifarnib


subject: UNII:9PE5MSX2YS

subject_name: DARLIFARNIB


subject: CHEBI:30879

subject_name: alcohol

object_name: opioid use


subject: CHEBI:16236

subject_name: Ethanol


subject: UMLS:C1883695

subject_name: Opioid Agonist [EPC]


subject: UMLS:C0721155

object_name: non-small cell lung carcinoma


subject: UMLS:C0721155

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C0721155

object_name: Stage IV Lung Cancer AJCC v7


subject: UMLS:C0721155

object_name: Stage IV Lung Cancer AJCC v6


subject: UMLS:C0721155

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C0721155

object_name: lung cancer


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:4466

object_name: COPD, severe early onset


subject: CHEBI:4466

object_name: chronic obstructive pulmonary disease


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UMLS:C3640210

subject_name: Iobenguane I-124

object_name: Childhood Neuroblastoma


subject: UMLS:C3640210

object_name: neuroblastoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Injury of kidney


subject: CHEBI:474053

subject_name: Cefazolin

object_name: arthropathy


subject: CHEBI:474053

object_name: Joint Infection, CTCAE


subject: CHEBI:474053

object_name: prosthesis-related infectious disease


subject: CHEBI:36796

subject_name: duloxetine

object_name: diabetic polyneuropathy


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:75722

subject_name: Tramadol

object_name: herpes zoster


subject: CHEBI:75722

object_name: postherpetic neuralgia


subject: CHEBI:75722


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: Anhedonia


subject: CHEBI:182913

object_name: mood disorder


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:8356


subject: CHEBI:131361

subject_name: disodium selenite pentahydrate

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:131361

object_name: ovarian cancer


subject: CHEBI:131361

object_name: ovarian neoplasm


subject: CHEBI:131361

object_name: ovarian carcinoma


subject: CHEBI:131361

object_name: primary peritoneal carcinoma


subject: CHEBI:131361

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:131361

object_name: peritoneal carcinoma


subject: CHEBI:131361

object_name: Recurrent ovarian cancer


subject: CHEBI:131361

object_name: fallopian tube carcinoma


subject: CHEBI:131361

object_name: fallopian tube cancer


subject: UMLS:C0886603

subject_name: Sodium Selenite Pentahydrate


subject: UMLS:C0886603


subject: UMLS:C0886603


subject: UMLS:C0886603


subject: UMLS:C0886603


subject: UMLS:C0886603


subject: UMLS:C0886603


subject: UMLS:C0886603


subject: UMLS:C0886603


subject: UMLS:C0886603


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: adrenocortical carcinoma, hereditary


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:38927

subject_name: Pelitinib

object_name: non-small cell lung carcinoma


subject: CHEBI:38927

object_name: lung neoplasm


subject: UMLS:C0306012

subject_name: dulcolax suppositories

object_name: Constipation


subject: UMLS:C0306012

object_name: Constipation, CTCAE


subject: UNII:058896B00B

subject_name: Naronapride

object_name: gastroparesis


subject: UNII:058896B00B

object_name: Gastroparesis, CTCAE


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: Consent Type - Hysterectomy


subject: UMLS:C2757070

subject_name: Progesterone [EPC]

object_name: Premature Labor


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:41879

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:29947

subject_name: glycine residue

object_name: morbid obesity


subject: CHEBI:29947

object_name: glycine metabolism disease


subject: CHEBI:15428

subject_name: Glycine


subject: CHEBI:15428


subject: CHEBI:135910

subject_name: Ganirelix

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: Postoperative Hemorrhage, CTCAE


subject: PUBCHEM.COMPOUND:27991

object_name: Intraoperative Hemorrhage


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: PUBCHEM.COMPOUND:16051933


subject: UMLS:C0086135

subject_name: DDAVP


subject: UMLS:C0086135

object_name: Postoperative Hemorrhage


subject: UMLS:C0086135


subject: UMLS:C3489770

object_name: childhood neoplasm


subject: UMLS:C3489770

object_name: neoplastic syndrome


subject: UMLS:C3489770

object_name: cancer or benign tumor


subject: UNII:082285VIDF

subject_name: fluoromisonidazole

object_name: adult glioblastoma


subject: UNII:082285VIDF

object_name: Adult Giant Cell Glioblastoma


subject: UNII:082285VIDF

object_name: Adult Gliosarcoma


subject: UMLS:C5787213

object_name: diabetic kidney disease


subject: UMLS:C5227675


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:1805

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:132082

subject_name: Entinostat


subject: CHEBI:132082


subject: CHEBI:132082

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:132082

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:132082


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: hepatitis C


subject: CHEBI:28793

subject_name: beta-D-glucan

object_name: arteriosclerosis disorder


subject: CHEBI:28793

object_name: atherosclerosis


subject: UMLS:C0796627

subject_name: Iomab-B

object_name: diffuse large B-cell lymphoma


subject: UMLS:C0796627

object_name: non-Hodgkin lymphoma


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: esophageal adenocarcinoma


subject: CHEBI:233362

object_name: esophageal squamous cell carcinoma


subject: CHEBI:233362

object_name: urothelial carcinoma


subject: UNII:UVJ7NL8S2P

subject_name: Imlifidase

object_name: chronic kidney disease


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: nonpapillary renal cell carcinoma


subject: UNII:6XG22YQM2Z

object_name: clear cell renal carcinoma


subject: UNII:6XG22YQM2Z

object_name: renal cell adenocarcinoma


subject: UNII:6XG22YQM2Z

object_name: renal cell carcinoma


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: CHEMBL.COMPOUND:CHEMBL5315001

subject_name: TOBEMSTOMIG


subject: CHEMBL.COMPOUND:CHEMBL5315001


subject: CHEMBL.COMPOUND:CHEMBL5315001


subject: CHEMBL.COMPOUND:CHEMBL5315001


subject: UMLS:C5417992

subject_name: Tobemstomig


subject: UMLS:C5417992


subject: UMLS:C5417992


subject: UMLS:C5417992


subject: CHEBI:132830

subject_name: delta-elemene

object_name: IDH-wildtype glioblastoma


subject: PUBCHEM.COMPOUND:10583

subject_name: (-)-cis-beta-Elemene


subject: UMLS:C4722543

subject_name: Toll-like Receptor 4 Agonist GLA-SE

object_name: Stage IV adult soft tissue sarcoma


subject: UMLS:C4722543

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: liver failure


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:231324

subject_name: alpelisib

object_name: human papillomavirus-related squamous cell carcinoma


subject: CHEBI:231324

object_name: HPV-related carcinoma


subject: CHEBI:231324

object_name: PIK3CA mutation-related tumors


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355

object_name: PIK3CA Gene Mutation


subject: CHEBI:15361

subject_name: pyruvate


subject: CHEBI:15361


subject: CHEBI:15361

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:15361

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:15361


subject: CHEBI:15361


subject: MESH:D011773

subject_name: Pyruvates


subject: MESH:D011773


subject: MESH:D011773


subject: MESH:D011773


subject: MESH:D011773


subject: MESH:D011773


subject: CHEBI:32816

subject_name: Pyruvic acid


subject: CHEBI:32816


subject: CHEBI:32816


subject: CHEBI:32816


subject: CHEBI:32816


subject: CHEBI:32816


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614

object_name: Stage IVB adult soft tissue sarcoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:90620

subject_name: Vatalanib

object_name: diffuse large B-cell lymphoma


subject: UMLS:C0912413

subject_name: PTK 787


subject: HMDB:HMDB0253501

subject_name: Insulin degludec

object_name: Critical Illness


subject: HMDB:HMDB0253501

object_name: hyperglycemia


subject: HMDB:HMDB0253501

object_name: Hyperglycemia, CTCAE


subject: HMDB:HMDB0253501

object_name: Glucose in blood specimen above reference range


subject: CHEBI:4856

subject_name: Esmolol

object_name: Myocardial Reperfusion Injury


subject: CHEBI:50693

subject_name: Milrinone


subject: CHEBI:5098

subject_name: Flucloxacillin

object_name: bacterial infectious disease


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: disease


subject: DRUGBANK:DB10571

subject_name: Strawberry

object_name: type 2 diabetes mellitus


subject: DRUGBANK:DB10571

object_name: Insulin resistance


subject: DRUGBANK:DB10571

object_name: metabolic disease


subject: DRUGBANK:DB10571

object_name: malnutrition


subject: CHEBI:132967

subject_name: Elbasvir

object_name: viral hepatitis


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Shoulder pain


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6741

subject_name: Meloxicam


subject: CHEBI:6741

object_name: opioid use


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:75722

subject_name: Tramadol


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: female infertility


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: vitamin C measurement


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Microsatellite Stable


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Unresectable Malignant Solid Neoplasm


subject: UMLS:C3896806


subject: CHEBI:131166

subject_name: Berzosertib


subject: CHEBI:131166

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:131166

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: septic shock


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: UMLS:C4086499

subject_name: Huaier Extract Granule

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C4086499

object_name: Carcinoma breast stage IV


subject: UMLS:C4086499

object_name: malignant neoplasm of breast stage IV


subject: GTOPDB:4934

subject_name: G-CSF

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: GTOPDB:4934

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:25136944

subject_name: Navelbine


subject: PUBCHEM.COMPOUND:25136944


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: MESH:C439566

subject_name: rV-Tricom

object_name: skin melanoma


subject: UMLS:C1675704

object_name: traumatic encephalopathy


subject: UMLS:C1675704

object_name: traumatic brain injury


subject: UMLS:C1675704

object_name: Parkinson disease


subject: UMLS:C1675704

object_name: Alzheimer disease


subject: UMLS:C1675704

object_name: stroke disorder


subject: UMLS:C1675704

object_name: cerebrovascular disorder


subject: UMLS:C1675704

object_name: Stroke (heart beat)


subject: UMLS:C1675704

object_name: Stroke, CTCAE


subject: CHEBI:7575

subject_name: Nimodipine

object_name: acoustic neuroma


subject: CHEMBL.COMPOUND:CHEMBL4650421

subject_name: RECOMBINANT HUMAN INTERLEUKIN-15

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: childhood malignant neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: brain neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: Childhood Neuroblastoma


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: neuroblastoma


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: malignant soft tissue neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650421

object_name: sarcoma


subject: UMLS:C1522569

subject_name: Interleukin-15, human recombinant


subject: UMLS:C1522569


subject: UMLS:C1522569


subject: UMLS:C1522569


subject: UMLS:C1522569


subject: UMLS:C1522569


subject: UMLS:C1522569


subject: CHEBI:4670

subject_name: Dobutamine

object_name: cardiovascular disorder


subject: UNII:349552KRHK

subject_name: Simendan


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:31348

object_name: High risk of


subject: CHEBI:31348

object_name: High risk


subject: CHEBI:31348

object_name: American College of Cardiology/American Heart Association Lesion Complexity Score C


subject: CHEBI:31348

object_name: High Risk Acute Leukemia


subject: CHEBI:31348

object_name: International Prognostic Index High Risk Group


subject: CHEBI:31348

object_name: Marinesco-Sjogren syndrome


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: GTOPDB:12989

subject_name: toripalimab

object_name: rectal carcinoma


subject: GTOPDB:12989

object_name: rectal cancer


subject: GTOPDB:12989

object_name: Childhood Rectal Carcinoma


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989

object_name: Microsatellite Stable


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: MESH:C050102

subject_name: measles, mumps, rubella, varicella vaccine

object_name: measles


subject: CHEBI:177564

subject_name: Irdabisant

object_name: Cognitive impairment


subject: UMLS:C3254381


subject: MESH:C000726227

object_name: kidney failure


subject: MESH:C000726227

object_name: Renal Failure, CTCAE


subject: UMLS:C2986994

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Stomach cancer


subject: CHEBI:49603

object_name: gastric cancer


subject: CHEBI:75431

subject_name: ghrelin

object_name: Cachexia


subject: CHEBI:75431

object_name: Advanced cancer


subject: DRUGBANK:DB11895

subject_name: Lenomorelin


subject: DRUGBANK:DB11895


subject: UMLS:C0911014


subject: UMLS:C0911014


subject: CHEBI:90227

subject_name: Selumetinib

object_name: malignant peripheral nerve sheath tumor


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Drug-induced Nephropathy


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: adenomyosis


subject: PUBCHEM.COMPOUND:53477758

object_name: leiomyoma


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Deep vein thrombosis of lower limb


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: APUdoma


subject: PUBCHEM.COMPOUND:14907381

object_name: pancreatic neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: pancreatic neuroendocrine tumor


subject: PUBCHEM.COMPOUND:14907381

object_name: Gastrointestinal Carcinoid Tumor


subject: PUBCHEM.COMPOUND:14907381

object_name: lung cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: neoplastic syndrome


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:74705

subject_name: Met-Leu

object_name: eosinophilic esophagitis


subject: CHEBI:74705

object_name: Eosinophilic infiltration of the esophagus


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: AIDS


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Gleason score


subject: PUBCHEM.COMPOUND:4454

subject_name: Neomycin sulfate

object_name: hordeolum externum


subject: PUBCHEM.COMPOUND:4454

object_name: hordeolum


subject: UNII:057Y626693

subject_name: NEOMYCIN SULFATE


subject: UNII:057Y626693


subject: CHEBI:31635

subject_name: neomycin sulfate


subject: CHEBI:31635


subject: CHEBI:7507

subject_name: Framycetin


subject: CHEBI:7507


subject: PUBCHEM.COMPOUND:4868

subject_name: polymyxin B


subject: PUBCHEM.COMPOUND:4868


subject: UNII:19371312D4

subject_name: POLYMYXIN B SULFATE


subject: UNII:19371312D4


subject: UMLS:C0001714

subject_name: polymyxin B sulfate


subject: UMLS:C0001714


subject: CHEBI:5530

subject_name: gramicidin


subject: CHEBI:5530


subject: PUBCHEM.COMPOUND:45267103

subject_name: Gramicidin D


subject: PUBCHEM.COMPOUND:45267103


subject: UMLS:C0018160


subject: UMLS:C0018160


subject: CHEBI:30860

subject_name: Methylmalonate

object_name: Solid Neoplasm


subject: CHEBI:30860

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C2700345

subject_name: Fluorine F-18 ML-10


subject: UMLS:C2700345


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: post-traumatic stress disorder


subject: PUBCHEM.COMPOUND:4715169

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: chronic pain (diagnosis)


subject: CHEBI:6887

object_name: Chronic pain


subject: CHEBI:3396

subject_name: Carbidopa-levodopa


subject: CHEBI:3396


subject: UMLS:C0353697

subject_name: carbidopa / levodopa


subject: UMLS:C0353697


subject: CHEBI:6427

subject_name: Leuprolide

object_name: adenomyosis


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Graft failure


subject: CHEBI:66919

object_name: sickle cell disease


subject: CHEBI:58097

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:90469070

subject_name: Descovy

object_name: HIV-1 infection


subject: CHEBI:133007


subject: PR:000004897

subject_name: complement C1s-1 subcomponent

object_name: hereditary angioedema


subject: PR:000004894

subject_name: complement C1s subcomponent


subject: UMLS:C0009504

subject_name: Complement C1s


subject: PR:000004898

subject_name: complement C1s-2 subcomponent


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: oral candidiasis


subject: CHEBI:46081

subject_name: Fluconazole


subject: PUBCHEM.COMPOUND:129628176

subject_name: Somatuline

object_name: dumping syndrome


subject: CHEBI:135901

subject_name: lanreotide


subject: UMLS:C0051846

subject_name: angiopeptin


subject: UMLS:C4721901

subject_name: Lanreotide Autogel


subject: UMLS:C0939333

subject_name: Estradiol Patch

object_name: Abnormal Mammogram


subject: UMLS:C0939333

object_name: Mammographic Breast Density


subject: CHEMBL.COMPOUND:CHEMBL5314347

subject_name: SEVELAMER CARBONATE

object_name: hyperphosphatemia


subject: CHEMBL.COMPOUND:CHEMBL5314347

object_name: Serum phosphate concentrations above normal (finding)


subject: CHEMBL.COMPOUND:CHEMBL5314347

object_name: Hyperphosphatemia, CTCAE


subject: UMLS:C1443151

subject_name: Gum arabic antigen

object_name: chemotherapy-induced oral mucositis


subject: MESH:D006170

subject_name: Gum Arabic


subject: UNII:1YTW0422YU

subject_name: Gum arabic


subject: UMLS:C2093618

subject_name: arabic gum allergenic extract


subject: DRUGBANK:DB10451

subject_name: Acacia


subject: CHEBI:600103

subject_name: daptomycin

object_name: skin disorder


subject: CHEMBL.COMPOUND:CHEMBL4297570

object_name: cancer


subject: CHEMBL.COMPOUND:CHEMBL4297570

object_name: neoplasm


subject: UMLS:C3273207


subject: UMLS:C3273207


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Physical function


subject: UMLS:C5556591


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: osteoarthritis, knee


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Injury of liver


subject: CHEBI:17026

subject_name: Progesterone

object_name: Luteal phase defect


subject: PUBCHEM.COMPOUND:49800000

subject_name: MECLIZINE HYDROCHLORIDE

object_name: Seasickness


subject: CHEBI:6709

subject_name: Meclizine


subject: CHEBI:7852

subject_name: Oxycodone

object_name: no feeling or sensation of skin


subject: CHEBI:7852

object_name: Sensory Loss


subject: UMLS:C0059079

subject_name: EMLA


subject: UMLS:C0059079


subject: UMLS:C0059079

object_name: childhood acute lymphoblastic leukemia


subject: UMLS:C0592557

subject_name: Ametop


subject: UMLS:C0592557


subject: UMLS:C0592557


subject: CHEBI:9468

subject_name: Tetracaine


subject: CHEBI:9468


subject: CHEBI:9468


subject: CHEBI:90943

subject_name: Osimertinib

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:90943

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:90943

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: CHEBI:90943

object_name: Stage IIIC Lung Cancer AJCC v8


subject: CHEBI:90943

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:230923

subject_name: Triptolide Analog


subject: CHEBI:230923

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:230923

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:230923


subject: CHEBI:230923

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:230923

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:230923


subject: CHEBI:230923


subject: CHEBI:230923


subject: CHEBI:230923

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UMLS:C3827767


subject: UMLS:C3827767


subject: UMLS:C3827767


subject: UMLS:C3827767


subject: UMLS:C3827767


subject: UMLS:C3827767


subject: UMLS:C3827767


subject: UMLS:C3827767


subject: UMLS:C3827767


subject: UMLS:C3827767


subject: UNII:D652ZWF066

subject_name: sodium zirconium cyclosilicate

object_name: metabolic acidosis


subject: UNII:D652ZWF066

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: foot fracture


subject: CHEBI:60802

subject_name: ropivacaine


subject: UMLS:C1176237

subject_name: Exubera

object_name: diabetes mellitus


subject: CHEBI:132922

object_name: neoplasm


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: chronic rhinosinusitis


subject: CHEBI:229220

subject_name: Repotrectinib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:229220

object_name: ROS1 gene rearrangement


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: hepatobiliary disorder


subject: CHEBI:59902

object_name: liver disorder


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: UMLS:C5198742

object_name: QT INTERVAL, VARIATION IN


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: childhood brain stem neoplasm


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:50453

subject_name: desferrioxamine

object_name: subarachnoid hemorrhage


subject: CHEBI:4356

subject_name: Deferoxamine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Locally Advanced Urothelial Carcinoma


subject: CHEBI:4026

object_name: Locally Advanced Endometrial Carcinoma


subject: CHEBI:4026

object_name: Locally Advanced Triple-Negative Breast Carcinoma


subject: CHEBI:4026

object_name: Locally Advanced Merkel Cell Carcinoma


subject: CHEBI:4026

object_name: Locally Advanced Skin Squamous Cell Carcinoma


subject: CHEBI:4026

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: CHEBI:4026

object_name: Locally Advanced Hepatocellular Carcinoma


subject: CHEBI:4026

object_name: Locally Advanced Gastric Adenocarcinoma


subject: CHEBI:4026

object_name: Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: CHEBI:4026

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:4026

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: CHEBI:4026

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:4026

object_name: Locally Advanced Unresectable Renal Cell Carcinoma


subject: CHEBI:4026

object_name: Locally Advanced Unresectable Cervical Carcinoma


subject: CHEBI:4026

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:4026

object_name: Locally Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4026

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: CHEBI:4026

object_name: Locally Advanced Unresectable Gastric Adenocarcinoma


subject: CHEBI:4026

object_name: Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4026

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: CHEBI:4026

object_name: Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: CHEBI:4026

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:4026

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4026

object_name: Unresectable Head and Neck Squamous Cell Carcinoma


subject: CHEBI:4026

object_name: Squamous cell carcinoma of head and neck metastatic


subject: CHEBI:4026

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4026

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: CHEBI:4026

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4026

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v8


subject: CHEBI:4026

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: CHEBI:4026

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: CHEBI:4026

object_name: Unresectable Endometrial Carcinoma


subject: CHEBI:4026

object_name: Unresectable Skin Squamous Cell Carcinoma


subject: CHEBI:4026

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:4026

object_name: Skin squamous cell carcinoma metastatic


subject: CHEBI:4026

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:4026

object_name: Unresectable Merkel Cell Carcinoma


subject: CHEBI:4026

object_name: Metastatic Merkel cell carcinoma


subject: CHEBI:4026

object_name: Unresectable Urothelial Carcinoma


subject: CHEBI:4026

object_name: Unresectable Gastric Adenocarcinoma


subject: CHEBI:4026

object_name: skin squamous cell carcinoma


subject: CHEBI:4026

object_name: Metastatic gastric adenocarcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: Locally Advanced Urothelial Carcinoma


subject: CHEBI:4027

object_name: Locally Advanced Endometrial Carcinoma


subject: CHEBI:4027

object_name: Locally Advanced Triple-Negative Breast Carcinoma


subject: CHEBI:4027

object_name: Locally Advanced Merkel Cell Carcinoma


subject: CHEBI:4027

object_name: Locally Advanced Skin Squamous Cell Carcinoma


subject: CHEBI:4027

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: CHEBI:4027

object_name: Locally Advanced Hepatocellular Carcinoma


subject: CHEBI:4027

object_name: Locally Advanced Gastric Adenocarcinoma


subject: CHEBI:4027

object_name: Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: CHEBI:4027

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:4027

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: CHEBI:4027

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: CHEBI:4027

object_name: Locally Advanced Unresectable Renal Cell Carcinoma


subject: CHEBI:4027

object_name: Locally Advanced Unresectable Cervical Carcinoma


subject: CHEBI:4027

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:4027

object_name: Locally Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4027

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: CHEBI:4027

object_name: Locally Advanced Unresectable Gastric Adenocarcinoma


subject: CHEBI:4027

object_name: Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4027

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: CHEBI:4027

object_name: Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: CHEBI:4027

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: CHEBI:4027

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: CHEBI:4027

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:4027

object_name: Unresectable Head and Neck Squamous Cell Carcinoma


subject: CHEBI:4027

object_name: Squamous cell carcinoma of head and neck metastatic


subject: CHEBI:4027

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4027

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: CHEBI:4027

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:4027

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v8


subject: CHEBI:4027

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: CHEBI:4027

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: CHEBI:4027

object_name: Unresectable Endometrial Carcinoma


subject: CHEBI:4027

object_name: Unresectable Skin Squamous Cell Carcinoma


subject: CHEBI:4027

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:4027

object_name: Skin squamous cell carcinoma metastatic


subject: CHEBI:4027

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:4027

object_name: Unresectable Merkel Cell Carcinoma


subject: CHEBI:4027

object_name: Metastatic Merkel cell carcinoma


subject: CHEBI:4027

object_name: Unresectable Urothelial Carcinoma


subject: CHEBI:4027

object_name: Unresectable Gastric Adenocarcinoma


subject: CHEBI:4027

object_name: skin squamous cell carcinoma


subject: CHEBI:4027

object_name: Metastatic gastric adenocarcinoma


subject: UMLS:C5237229

subject_name: Neoantigen Peptide Vaccine

object_name: Locally Advanced Melanoma


subject: UMLS:C5237229

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C5237229

object_name: Locally Advanced Renal Cell Carcinoma


subject: UMLS:C5237229

object_name: Locally Advanced Cervical Carcinoma


subject: UMLS:C5237229

object_name: Stage III Lung Cancer AJCC v8


subject: UMLS:C5237229

object_name: Locally Advanced Urothelial Carcinoma


subject: UMLS:C5237229

object_name: Locally Advanced Endometrial Carcinoma


subject: UMLS:C5237229

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C5237229

object_name: Locally Advanced Triple-Negative Breast Carcinoma


subject: UMLS:C5237229

object_name: Stage III Cervical Cancer AJCC v8


subject: UMLS:C5237229

object_name: Locally Advanced Merkel Cell Carcinoma


subject: UMLS:C5237229

object_name: Locally Advanced Skin Squamous Cell Carcinoma


subject: UMLS:C5237229

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UMLS:C5237229

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C5237229

object_name: Locally Advanced Hepatocellular Carcinoma


subject: UMLS:C5237229

object_name: Locally Advanced Gastric Adenocarcinoma


subject: UMLS:C5237229

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C5237229

object_name: Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: UMLS:C5237229

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: UMLS:C5237229

object_name: Stage IVA Lung Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IVB Lung Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: UMLS:C5237229

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: UMLS:C5237229

object_name: Locally Advanced Unresectable Renal Cell Carcinoma


subject: UMLS:C5237229

object_name: Stage IV Cervical Cancer AJCC v8


subject: UMLS:C5237229

object_name: Locally Advanced Unresectable Breast Carcinoma


subject: UMLS:C5237229

object_name: Locally Advanced Unresectable Cervical Carcinoma


subject: UMLS:C5237229

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UMLS:C5237229

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C5237229

object_name: Locally Advanced Gastroesophageal Junction Adenocarcinoma


subject: UMLS:C5237229

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: UMLS:C5237229

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage III Gastric Cancer AJCC v8


subject: UMLS:C5237229

object_name: Locally Advanced Unresectable Gastric Adenocarcinoma


subject: UMLS:C5237229

object_name: Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma


subject: UMLS:C5237229

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5237229

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C5237229

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: UMLS:C5237229

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C5237229

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C5237229

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IIIC Gastric Cancer AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IIIB Gastric Cancer AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IIIA Gastric Cancer AJCC v8


subject: UMLS:C5237229

object_name: Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5237229

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5237229

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: UMLS:C5237229

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UMLS:C5237229

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C5237229

object_name: Clinical Stage IVA Gastric Cancer AJCC v8


subject: UMLS:C5237229

object_name: Clinical Stage IVB Gastric Cancer AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IV Gastric Cancer AJCC v8


subject: UMLS:C5237229

object_name: Unresectable Malignant Solid Neoplasm


subject: UMLS:C5237229

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: UMLS:C5237229

object_name: Unresectable Head and Neck Squamous Cell Carcinoma


subject: UMLS:C5237229

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UMLS:C5237229

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: UMLS:C5237229

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: UMLS:C5237229

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: UMLS:C5237229

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C5237229

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C5237229

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v8


subject: UMLS:C5237229

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UMLS:C5237229

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UMLS:C5237229

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: UMLS:C5237229

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UMLS:C5237229

object_name: Unresectable Endometrial Carcinoma


subject: UMLS:C5237229

object_name: Unresectable Lung Non-Small Cell Carcinoma


subject: UMLS:C5237229

object_name: Unresectable Skin Squamous Cell Carcinoma


subject: UMLS:C5237229

object_name: Stage IVA Hepatocellular Carcinoma AJCC v8


subject: UMLS:C5237229

object_name: Stage IVB Hepatocellular Carcinoma AJCC v8


subject: UMLS:C5237229

object_name: Metastatic Endometrial Carcinoma


subject: UMLS:C5237229

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C5237229

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UMLS:C5237229

object_name: Skin squamous cell carcinoma metastatic


subject: UMLS:C5237229

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: UMLS:C5237229

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C5237229

object_name: Unresectable Renal Cell Carcinoma


subject: UMLS:C5237229

object_name: Unresectable Hepatocellular Carcinoma


subject: UMLS:C5237229

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C5237229

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C5237229

object_name: Unresectable Merkel Cell Carcinoma


subject: UMLS:C5237229

object_name: Metastatic hepatocellular carcinoma


subject: UMLS:C5237229

object_name: Metastatic Merkel cell carcinoma


subject: UMLS:C5237229

object_name: Unresectable Urothelial Carcinoma


subject: UMLS:C5237229

object_name: triple-negative breast carcinoma


subject: UMLS:C5237229

object_name: Metastatic urothelial carcinoma


subject: UMLS:C5237229

object_name: Unresectable Gastric Adenocarcinoma


subject: UMLS:C5237229

object_name: skin squamous cell carcinoma


subject: UMLS:C5237229

object_name: Unresectable Cervical Carcinoma


subject: UMLS:C5237229

object_name: Metastatic gastric adenocarcinoma


subject: UMLS:C5237229

object_name: Metastatic Cervical Carcinoma


subject: UMLS:C5237229

object_name: Unresectable Melanoma


subject: UMLS:C5237229

object_name: metastatic melanoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Locally Advanced Melanoma


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Renal Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Cervical Carcinoma


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Endometrial Carcinoma


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Triple-Negative Breast Carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage III Cervical Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Merkel Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Skin Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Hepatocellular Carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Unresectable Renal Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage IV Cervical Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Unresectable Breast Carcinoma


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Unresectable Cervical Carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Unresectable Gastric Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Unresectable Endometrial Carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage IVA Hepatocellular Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IVB Hepatocellular Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Metastatic Endometrial Carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Unresectable Merkel Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Metastatic Merkel cell carcinoma


subject: UNII:DPT0O3T46P

object_name: Unresectable Cervical Carcinoma


subject: UNII:DPT0O3T46P

object_name: Metastatic Cervical Carcinoma


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Locally Advanced Melanoma


subject: UNII:5TAA004E22

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UNII:5TAA004E22

object_name: Locally Advanced Renal Cell Carcinoma


subject: UNII:5TAA004E22

object_name: Locally Advanced Cervical Carcinoma


subject: UNII:5TAA004E22

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Locally Advanced Urothelial Carcinoma


subject: UNII:5TAA004E22

object_name: Locally Advanced Endometrial Carcinoma